secwatch.observer — SEC 8-K summary
======================================

Issuer:     HALOZYME THERAPEUTICS, INC. (HALO)
CIK:        0001159036
Form:       8-K
Filed at:   2024-04-26T23:59:59+00:00
Accession:  0001159036-24-000031
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Halozyme stockholders elect directors, approve executive compensation and charter amendment at 2024 annual meeting
--------------------------------------------------------------------------------

- Barbara Duncan elected with 90.1M votes for, Mahesh Krishnan with 104.0M votes for, each to three-year term.
- Advisory vote on named executive officer compensation passed 102.9M for vs 2.2M against.
- Amendment to certificate of incorporation to exculpate officers approved 91.5M for vs 13.6M against; filed with Delaware on April 25.
- Ratification of Ernst & Young as auditor for FY2024 passed 114.9M for vs 0.6M against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1159036/000115903624000031/0001159036-24-000031-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1159036/000115903624000031/halo-20240425.htm
  HTML page:      https://secwatch.observer/filing/0001159036-24-000031

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer